Clinical Trial Update: Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

View source ↗

Summary

This five-year observational study reports results for Remicade (infliximab) in plaque psoriasis in Austria. The trial is completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2011-09-02